medmix AG (MEDX) - Total Assets
Based on the latest financial reports, medmix AG (MEDX) holds total assets worth CHF969.30 Million CHF (≈ $1.23 Billion USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
medmix AG - Total Assets Trend (2018–2025)
This chart illustrates how medmix AG's total assets have evolved over time, based on quarterly financial data. Also see market cap of medmix AG for the company's overall valuation and market capitalisation.
medmix AG - Asset Composition Analysis
Current Asset Composition (December 2025)
medmix AG's total assets of CHF969.30 Million consist of 27.4% current assets and 72.6% non-current assets. Review total liabilities of medmix AG to assess the company's total debt and financial obligations.
| Asset Category | Amount (CHF) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CHF3.00 Million | 10.9% |
| Accounts Receivable | CHF68.50 Million | 7.1% |
| Inventory | CHF76.00 Million | 7.8% |
| Property, Plant & Equipment | CHF269.00 Million | 27.8% |
| Intangible Assets | CHF103.50 Million | 10.7% |
| Goodwill | CHF266.50 Million | 27.5% |
Asset Composition Trend (2018–2025)
This chart illustrates how medmix AG's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See latest medmix AG stock price today for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: medmix AG's current assets represent 27.4% of total assets in 2025, a decrease from 29.9% in 2018.
- Cash Position: Cash and equivalents constituted 10.9% of total assets in 2025, up from 2.3% in 2018.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 37.0% of total assets, a decrease from 52.0% in 2018.
- Asset Diversification: The largest asset category is property, plant & equipment at 27.8% of total assets.
medmix AG Competitors by Total Assets
Key competitors of medmix AG based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
SCHNEIDER ELECTR.ADR/1/5
F:SNDB
|
Germany | €62.50 Billion |
|
Sandvik AB
ST:SAND
|
Sweden | Skr182.23 Billion |
|
NARI Technology Co Ltd
SHG:600406
|
China | CN¥95.86 Billion |
|
Zhejiang Sanhua Co Ltd
SHE:002050
|
China | CN¥49.36 Billion |
|
Wuxi Lead Auto Equipment Co Ltd
SHE:300450
|
China | CN¥49.83 Billion |
|
Beijing Roborock Technology Co Ltd
SHG:688169
|
China | CN¥19.59 Billion |
|
Xi an Bright Laser Tech Co Ltd
SHG:688333
|
China | CN¥8.60 Billion |
|
Avic Aviation High Technology Co Ltd
SHG:600862
|
China | CN¥10.76 Billion |
medmix AG - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.54 | 1.60 | 1.15 |
| Quick Ratio | 1.10 | 1.14 | 0.68 |
| Cash Ratio | 0.61 | 0.72 | 0.11 |
| Working Capital | CHF93.40 Million | CHF98.30 Million | CHF20.10 Million |
medmix AG - Advanced Valuation Insights
This section examines the relationship between medmix AG's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.81 |
| Latest Market Cap to Assets Ratio | 0.36 |
| Asset Growth Rate (YoY) | 1.6% |
| Total Assets | CHF969.30 Million |
| Market Capitalization | $352.23 Million USD |
Valuation Analysis
Below Book Valuation: The market values medmix AG's assets below their book value (0.36x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: medmix AG's assets grew by 1.6% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for medmix AG (2018–2025)
The table below shows the annual total assets of medmix AG from 2018 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CHF969.30 Million ≈ $1.23 Billion |
+1.58% |
| 2024-12-31 | CHF954.20 Million ≈ $1.21 Billion |
-5.22% |
| 2023-12-31 | CHF1.01 Billion ≈ $1.27 Billion |
-8.96% |
| 2022-12-31 | CHF1.11 Billion ≈ $1.40 Billion |
+13.50% |
| 2021-12-31 | CHF974.40 Million ≈ $1.23 Billion |
+23.36% |
| 2020-12-31 | CHF789.90 Million ≈ $998.65 Million |
+13.33% |
| 2019-12-31 | CHF697.00 Million ≈ $881.20 Million |
-2.94% |
| 2018-12-31 | CHF718.10 Million ≈ $907.87 Million |
-- |
About medmix AG
medmix AG designs, produces, and sells high-precision devices and services in Switzerland and internationally. It operates through the Healthcare, and Consumer and Industrial segments. The company offers dispensers, cartridges, mixers, tips, syringes, pen, and auto injectors for delivery of dental materials; delivery devices and mixing for bone repair and tissue treatment, which are used for pros… Read more